Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy report episodes of shaking or trembling, usually mild and short-lived. The shaking is real, but the most common explanation floating around online is wrong — most Wegovy-related shaking is not a sign that the medicine is too strong or that something has gone seriously wrong. Understanding what is actually causing it matters, because the right response depends on the right cause. Wegovy (semaglutide) is a prescription-only medicine; a GLP-1 treatment for weight management that requires clinical assessment before it can be prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The version of events most often posted in weight-loss communities runs something like this: shaking means the dose is too high, or semaglutide is "overwhelming" the body. Neither is accurate as a general rule. Semaglutide works by mimicking a gut hormone, slowing gastric emptying and signalling fullness to the brain. It does not directly stimulate muscle contraction or disrupt the nervous system in a way that would cause trembling as a primary effect.
What it does do, powerfully, is suppress appetite. People eating far less than usual (sometimes skipping meals without noticing because hunger has simply disappeared) can end up with blood sugar that drops lower than their body is used to. That dip, even a modest one, triggers the classic physiological stress response: adrenaline release, a racing heart, sweating, and yes, shaking. The shaking is the body's signal, not semaglutide's direct action.
The distinction matters practically. If the cause is erratic eating, the fix is regular small meals with adequate protein, not stopping treatment. If the cause is something else entirely, that needs identifying. The mechanism behind how semaglutide works helps explain why appetite suppression can outpace a person's awareness of how little they have eaten that day.
Low blood sugar (hypoglycaemia) is the leading candidate when shaking appears in the hours after a missed or very small meal. People without diabetes can experience reactive dips, especially when their calorie intake drops sharply. Eating a small carbohydrate-containing snack tends to resolve the episode within fifteen or twenty minutes.
Dehydration runs a close second. Nausea and reduced appetite mean some people drink far less than usual, particularly in the early weeks. Dehydration affects electrolyte balance and can produce light-headedness, weakness, and a shaky feeling that is easy to mistake for something more alarming. Sipping water steadily through the day, rather than trying to catch up in one go, tends to help. If nausea is contributing to poor fluid intake, it is worth reading about gastrointestinal side effects during treatment for practical context.
Anxiety also surfaces here more than people expect. Starting a new medicine, adjusting to physical changes, and worrying about whether something felt is a side effect can itself generate a stress response, which produces shaking. Acknowledging that is not dismissive; it is clinically accurate.
Finally, a small number of people experience tremor or shakiness as part of a broader hypersensitivity or autonomic response. This is less common, harder to attribute to a single cause, and worth raising directly with the prescribing clinician rather than self-managing. The full detail on tremor and shaking during semaglutide treatment covers those less straightforward presentations.
Most shaking on Wegovy is short-lived and resolves with food, fluid, or rest. The NHS guidance on semaglutide sets out when to seek help promptly, and it is worth knowing those thresholds before you need them.
Call 111 or seek urgent care if shaking is accompanied by severe, persistent stomach pain that spreads to the back, this combination can indicate pancreatitis, a known though infrequent risk with GLP-1 medicines that the MHRA's Yellow Card scheme asks healthcare professionals and patients to report. Also seek help for shaking paired with a fast or irregular heartbeat that does not settle, signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), or any episode where you lose coordination, feel faint, or cannot determine the cause.
For people with type 2 diabetes taking other glucose-lowering medicines alongside semaglutide, the risk of hypoglycaemia is higher and the threshold for checking blood sugar should be lower. That is a conversation for your prescriber, not a problem to manage alone.
If you are weighing up whether Wegovy suits your situation, the cost and access information for Wegovy is worth reviewing alongside the clinical picture, and our frequently asked questions cover a range of practical concerns. If you have an ongoing question or a side effect you are unsure about, the team at nume support is available seven days a week.
Before concluding shaking means something is wrong with your treatment, run through the straightforward checklist. Have you eaten in the last four to five hours? Even a small, protein-containing snack (a handful of nuts, a boiled egg, some Greek yogurt) can stabilise blood sugar within minutes. Have you had enough water today? A large glass is a reasonable first response to any vague physical complaint during the early weeks of treatment.
Timing also matters. Many people find shakiness is most likely first thing in the morning, before eating, or late afternoon when meals have been light. Redistributing calories slightly across the day, rather than eating one large evening meal, often helps. These adjustments are the kind of thing our clinical team routinely discusses with patients during aftercare, it is one of the reasons having a prescriber available after starting treatment makes a practical difference.
Wegovy is a prescription medicine manufactured by Novo Nordisk, and you can read more about who makes Wegovy and their role in its development if you want to understand the background before starting treatment. If you are thinking about starting treatment or have questions about whether it is right for you, the right first step is a consultation rather than self-diagnosis from a symptom search. Start your free consultation with our prescribers to get a clinical view of your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.